Postmarket Study Confirms Xience Stent Safety MedPage Today By Todd Neale, Senior Staff Writer, MedPage Today The everolimus-eluting (XIENCE V) stent performs in everyday clinical practice much as it did in pre-approval trials. There were no cases of late stent thrombosis when dual antiplatelet therapy was ... |
